Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488509 · ClinicalTrials.gov registry record · Phase 2
Acute Effects of Cannabis on Everyday Life Memory
A Phase 2 study, sponsored by Washington State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
NCT05488509 is a Phase 2 study that has completed, run by Washington State University. The registered enrollment target is 121 participants.
The verdict
NCT05488509, a Phase 2 study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
Study Summary
This study will examine the acute effects of cannabis on various aspects of memory. Eligible participants will complete a drug screen. Participants who pass the drug screen will be asked to wear an Empatica E4 wristband for the duration of the study. Participants will provide a saliva sample from which cortisol will be extracted. They will then complete baseline measures of cannabis consumption patterns, level of intoxication, mood, anxiety, stress, and verbal intelligence. Next, participants will be randomly assigned to inhale vapor from cannabis containing 20mg THC, 40mg THC, or placebo; both cannabis and placebo will be obtained from the National Institute on Drug Abuse (NIDA). Participants will then will complete a battery of memory tests including tests of prospective, verbal, visuospatial, source, verbal working, visuospatial working, false, and temporal order memory. Memory tests will be completed across two blocks in a counterbalanced order. Saliva samples will be obtained two additional times after drug/placebo administration. Ratings of intoxication, mood, anxiety, and stress will be obtained three additional times after drug/placebo administration. The investigators hypothesize that participants who are randomly assigned to inhale cannabis vapor will perform worse on all memory tests than participants who inhale the placebo.
Interventions
- DRUG Placebo
- DRUG Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2025-05-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05488509
The ClinicalTrials.gov registry entry for NCT05488509 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05488509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05488509 about?
NCT05488509 is a clinical study titled "Acute Effects of Cannabis on Everyday Life Memory". This study will examine the acute effects of cannabis on various aspects of memory. Eligible participants will complete a drug screen. Participants who pass the drug screen will be asked to wear an Empatica E4 wristband for the duration of the study. Participants will provide a saliva sample from wh...
What is the current status of trial NCT05488509?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2023-08-21. Estimated completion is 2025-05-17.
What interventions are being tested in trial NCT05488509?
The interventions under investigation include: Placebo (DRUG), Cannabis (DRUG).
Who is sponsoring clinical trial NCT05488509?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.